Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Low body weight linked to PML risk with natalizumab in MS
A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe.
Patient Characteristics Associated with Medication Adherence.
The effects of exercise training on fitness, mobility, fatigue, and health related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development.
Neuropathic pain in animal models of nervous system autoimmune diseases.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
The structure and function of the S1P1 receptor.
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
A Discrete Choice Experiment to Determine Patient Preferences for Injection Devices in Multiple Sclerosis.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Novel insights into the development and maintenance of the blood-brain barrier.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Plasma Exchange Is Effective in a 13-Year-Old Girl with Steroid-Resistant Bilateral Optic Neuritis.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »